LENZ Therapeutics, Inc. — Investor Relations & Filings
Filings indexed
329
across all filing types
Latest filing
2026-04-28
Annual Report
Country
US
United States of America
Listing
US
LENZ
LENZ Therapeutics, Inc. is a late-stage pharmaceutical company focused on developing and commercializing ophthalmic therapies to improve vision. Its primary product is VIZZ™ (aceclidine ophthalmic solution) 1.44%, an FDA-approved eye drop for the treatment of presbyopia, the age-related loss of near vision. VIZZ is the first aceclidine-based therapy for this condition, which affects an estimated 1.8 billion people globally. The product is designed to restore near vision, providing a pharmaceutical alternative to reading glasses for a broad patient population.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - LENZ Therapeutics, Inc. (0001815776) (Filer) | 2026-04-28 | English | |
| 4 - LENZ Therapeutics, Inc. (0001815776) (Issuer) | 2026-03-30 | English | |
| 4 - LENZ Therapeutics, Inc. (0001815776) (Issuer) | 2026-03-30 | English | |
| 4 - LENZ Therapeutics, Inc. (0001815776) (Issuer) | 2026-03-30 | English | |
| 8-K - LENZ Therapeutics, Inc. (0001815776) (Filer) | 2026-03-24 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
13 filings
| |||||
| 38172642 | ARS - LENZ Therapeutics, Inc. (0001815776) (Filer) | 2026-04-28 | English | ||
| 33088240 | 4 - LENZ Therapeutics, Inc. (0001815776) (Issuer) | 2026-03-30 | English | ||
| 33088239 | 4 - LENZ Therapeutics, Inc. (0001815776) (Issuer) | 2026-03-30 | English | ||
| 33088238 | 4 - LENZ Therapeutics, Inc. (0001815776) (Issuer) | 2026-03-30 | English | ||
| 33031540 | 8-K - LENZ Therapeutics, Inc. (0001815776) (Filer) | 2026-03-24 | English | ||
| 31841011 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 31841046 | SCHEDULE 13G/A Filing | 2026-02-05 | English | ||
| 13265430 | Major Shareholding Notification 2026 | 2026-01-21 | English | ||
| 13265429 | 8-K | 2026-01-07 | English | ||
| 13265431 | FORM 4 | 2026-01-06 | English | ||
| 13265432 | FORM 4 | 2026-01-06 | English | ||
| 13265433 | FORM 4 | 2026-01-06 | English | ||
| 13265434 | FORM 4 | 2026-01-06 | English | ||
|
2025
2 filings
| |||||
| 13265435 | 8-K | 2025-12-12 | English | ||
| 13265436 | FORM 4 | 2025-11-20 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Hangzhou Tianmushan Pharmaceutical Enterprise Co.,Ltd
Produces TCM, chemical drugs, and health supplements for di…
|
600671 | CN | Manufacturing |
|
Hanmi Pharm. Co., Ltd.
A research-oriented biopharmaceutical company developing an…
|
128940 | KR | Manufacturing |
|
Hanmi Science Co.,Ltd
A holding company managing subsidiaries in the pharmaceutic…
|
008930 | KR | Manufacturing |
|
Hansa Biopharma
Develops antibody-cleaving enzyme technology for rare immun…
|
HNSA | SE | Manufacturing |
|
Hansoh Pharmaceutical Group Company Limited
Leading innovation-driven biopharmaceutical enterprise deve…
|
3692 | KY | Manufacturing |
|
Hanx Biopharmaceuticals (Wuhan) Co., Ltd.
Clinical-stage biopharma developing immuno-oncology therapi…
|
3378 | HK | Manufacturing |
|
Harbin Fuerjia Technology Co., Ltd.
Develops medical dressings and functional cosmetics for ski…
|
301371 | CN | Manufacturing |
|
HARBIN GLORIA PHARMACEUTICALS Co., LTD
Develops and produces drugs for cardiovascular, orthopedic,…
|
002437 | CN | Manufacturing |
|
HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.
Produces injections and oral drugs for cardiovascular, gast…
|
002900 | CN | Manufacturing |
|
Harbin Pharmaceutical Group Co.,Ltd.
Researches and manufactures pharmaceuticals, OTC drugs, and…
|
600664 | CN | Manufacturing |
LENZ Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32045/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32045 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32045 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32045 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32045}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for LENZ Therapeutics, Inc. (id: 32045)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.